VEGFA and Alzheimer disease: (29) reported that AD-MSC-EV-miR-26a-5p alleviated both the ECM accumulation in kidney tissues and the thickening of basement membrane, and inhibited apoptosis in mouse podocytes in vitro by inhibiting signaling pathways of NF-κB/VEGFA and TLR4.